Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to determine the incidence and impact of brain lesions in MRI after coiling and clipping of unruptured intracranial aneurysms on clinical and neurological outcome of patients.


Clinical Trial Description

Silent ischemic lesions after treatment of unruptured intracranial aneurysm (UIA) might alter patients' clinical and neurological outcome. Furthermore silent brain lesions are not well documented after endovascular and surgical treatment of unruptured intracranial aneurysms. Therefore, the investigators investigate the incidence and influence of treatment-related ischemic lesions in magnetic resonance / diffusion-weighted-imaging after endovascular and surgical treatment of UIA. ;


Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


NCT number NCT01490463
Study type Observational
Source Johann Wolfgang Goethe University Hospitals
Contact
Status Completed
Phase N/A
Start date August 2011
Completion date January 2013

See also
  Status Clinical Trial Phase
Recruiting NCT03063541 - Acetylsalicylic Acid Plus Intensive Blood Pressure Treatment in Patients With Unruptured Intracranial Aneurysms Phase 3
Completed NCT02862756 - Analysis of Thrombo-embolic Complications After Endovascular Treatment of Unruptured Intracranial Aneurysms N/A
Not yet recruiting NCT03462433 - Treatment of Ruptured Intracranial Aneurysms in China.